; (B) a listed patent for which a certification has been submitted under subsection (b)(2)(A)(iii) or (j)(2)(A)(vii)(III) of section 505; or (C) a listed patent for which a certification has been submitted under subsection (b)(2)(A)(iv) or (j)(2)(A)(vii)(IV) of section 505 if in the patent infringement litigation resulting from the certification the court determines that the patent is valid and would be infringed, shall be extended after the date the listed patent expires (including any patent extensions) for a period equal to the conveyed exclusivity extension period. (d) Timing of conveyance and notice The conveyance of an exclusivity extension period pursuant to subsection (a) and the provision of notice under subsection (b) shall be made no later than— (1) in the case of a priority antimicrobial product that is a drug, the last day of the ninth year of the 5-year period described in subsections (c)(3)(E)(ii) and (j)(5)(F)(ii), as extended, as applicable, under section 505E